Back
Verisk Analytics Vs. Monopar Therapeutics Industry Stock Comparison
Buy
63
VRSK
Verisk Analytics
Last Price:
$285.13
Seasonality Move:
5.59%
Buy
63
MNPR
Monopar Therapeutics
Last Price:
$41.15
Seasonality Move:
-13.48%
Buy
63
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $287.68. The Score for VRSK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $44.74. The Score for MNPR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $287.68Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing slight selling pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $44.74Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight buying pressure.
VRSK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.25 | Sell |
Relative Strength Index (14 RSI): | 44.53 | Sell |
Chaikin Money Flow: | -23676 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (289.33 - 297.53) | Sell |
Bollinger Bands (100): | (275.38 - 293.22) | Buy |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 65.97 | Buy |
Chaikin Money Flow: | 17636 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.51 - 43.49) | Buy |
Bollinger Bands (100): | (17.77 - 38.71) | Buy |
VRSK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 289.25 | Sell |
20-day SMA: | 293.3 | Sell |
50-day SMA: | 287.67 | Buy |
200-day SMA: | 276.6 | Buy |
8-day EMA: | 290.14 | Sell |
20-day EMA: | 291.5 | Sell |
50-day EMA: | 289 | Sell |
200-day EMA: | 274.79 | Buy |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.98 | Buy |
20-day SMA: | 33.94 | Buy |
50-day SMA: | 36.1 | Buy |
200-day SMA: | 15.99 | Buy |
8-day EMA: | 36.12 | Buy |
20-day EMA: | 35.35 | Buy |
50-day EMA: | 34.05 | Buy |
200-day EMA: | 20.66 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Verisk Analytics Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |